Exclusive

Publication

Byline

Location

US Patent Issued to The University of North Carolina at Chapel Hill on April 7 for "Potentiation of antibiotic effect" (North Carolina Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,289, issued on April 7, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.). "Potentiation of antibiotic ef... Read More


US Patent Issued to SANIFIT THERAPEUTICS on April 7 for "IP and IP analogs dosage regimens for the treatment of ectopic calcifications" (Spanish Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,290, issued on April 7, was assigned to SANIFIT THERAPEUTICS S.A. (Palma de Mallorca, Spain). "IP and IP analogs dosage regimens for the tr... Read More


US Patent Issued to Alpha Tau Medical on April 7 for "Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen" (Israeli Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,291, issued on April 7, was assigned to Alpha Tau Medical Ltd (Jerusalem). "Intratumoral alpha-emitter radiation and activation of cytoplas... Read More


US Patent Issued to The Regents of the University of California on April 7 for "Antiviral prodrugs, intermediate-and long-acting formulations and methods" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,292, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.). "Antiviral prodrugs, intermediate-an... Read More


US Patent Issued to The Board of Regents of The University of Texas System, Children's Hospital Medical Center on April 7 for "Use of 6-thio-dG to treat therapy-resistant telomerasepositive pediatric brain tumors" (Texas, Ohio Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,293, issued on April 7, was assigned to The Board of Regents of The University of Texas System (Austin, Texas) and Children's Hospital Medic... Read More


US Patent Issued to The University of Tokyo, Yamaguchi University on April 7 for "Therapeutic and prophylactic agent for glioma, brain tumor malignancy marker, brain tumor prognostic marker, method for determining malignancy and prognosis of brain tumor and antibody inhibiting tumor proliferation" (Japanese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,294, issued on April 7, was assigned to The University of Tokyo (Tokyo) and Yamaguchi University (Yamaguchi, Japan). "Therapeutic and proph... Read More


US Patent Issued to TRANSLATE BIO, ETHRIS on April 7 for "CFTR mRNA compositions and related methods and uses" (German, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,295, issued on April 7, was assigned to TRANSLATE BIO INC. (Waltham, Mass.) and ETHRIS GMBH (Planegg, Germany). "CFTR mRNA compositions and... Read More


US Patent Issued to SYNEDGEN on April 7 for "Methods for treatment or prevention of damage resulting from radiation, trauma or shock" (California, Maryland Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,296, issued on April 7, was assigned to SYNEDGEN INC. (Claremont, Calif.). "Methods for treatment or prevention of damage resulting from ra... Read More


US Patent Issued to Medicrinia on April 7 for "Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury" (South Korean Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,297, issued on April 7, was assigned to Medicrinia Co. Ltd. (Seoul, South Korea). "Composition comprising hyaluronic acid and pluronic for ... Read More


US Patent Issued to Azurity Pharmaceuticals on April 7 for "Methods of administering safe colon cleansing compositions" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,298, issued on April 7, was assigned to Azurity Pharmaceuticals Inc. (Woburn, Mass.). "Methods of administering safe colon cleansing compos... Read More